USPTO Notice of Allowance for Nicotine Replacement Therapy Patent Using Synthetic Nicotine
Notice of Allowance helps establish the potential for use of the R and S isomers of Synthetic Nicotine in future nicotine replacement and smoking cessation products
SAN DIEGO, Aug. 25, 2019 /PRNewswire-PRWeb/ — Next Generation Labs, the sole manufacturer of TFN® nicotine, the world’s only bulk Synthetic Nicotine not made from, or derived from tobacco, has received a Notice of Allowance from the US Patent and Trade Mark Office (USPTO) in US 2017-0189388 for methods of treating nicotine addiction using a Synthetic Nicotine protocol.
The patent application, titled “Nicotine replacement therapy products comprising Synthetic Nicotine,” specifically claims a method for administration of a first ratio of synthetic R and S nicotine, and a subsequent administration of a second and different ratio of synthetic R and S nicotine. The Synthetic Nicotine used in the administrations includes a “nicotine product comprising a synthetic nicotine substantially free of one or more of nicotine-1?-N-oxide, nicotyrine, nornicotyrine, cotinine, 2?,3-bipyridyl, anabasine, N-methyl anatabine, N-methyl anabasine, anabasine, and/or anatabine.” The composition further includes one or more pharmaceutically acceptable excipients, additives and/or carriers.
Next Generation Labs is pleased this patent application has been allowed, as it helps establish the potential for use of the R and S isomers of Synthetic Nicotine in future nicotine replacement and smoking cessation products. R and S Synthetic Nicotine technology could become a significant component product ingredient in all smoking cessation products, as it finally gives the global pharmaceutical industry a viable alternative to the tobacco-derived nicotine that is currently used in all nicotine replacement products sold worldwide.
Given anticipated interest in the use of R-S nicotine in cessation products, Next Generation Labs will be offering its R-S, S and R nicotine products to companies in the pharmaceutical industry, under the brand name PharmaNic®.
We specialize in manufacturing chemical Synthetic Nicotine ( CAS No.: 54-11-5 ) in China. we have the highest technology and stable quality control , our factory has sophisticated technology production route to produce the above products ,welcome to inquiry it .Please contact us by e-mail firstname.lastname@example.org for quotation requests. Please provide quantity, purity, and any other specific requirements.http://www.synthetic-nicotine.net/uspto-notice-of-allowance-for-nicotine-replacement-therapy-patent-using-synthetic-nicotine/Synthetic Nicotine is used for Medical and Drug